Anti-inflammatory effect of flavonoids from Comfort-G and the changes in arachidonic acid metabolism

Klinicka Biochemie a Metabolismus

Volumn 16, Issue 1, 2008, Pages 27-32

  Vecka, Marek ^a   Prokes L ^b   Tvrzicka E ^a   Karpas K ^b   Pernicky A ^c   Pfleger, R ^d   Votruba, M ^e  

^a CHARLES UNIVERSITY   (Czech Republic)

^b UNIVERSITY HOSPITAL HRADEC KRALOVE   (Czech Republic)

^c Sevapharma as   (Czech Republic)

^d BioPol GN Ltd   (Czech Republic)

^e Mi Vo La Consulting   (Czech Republic)

Author keywords

5 LO; Arachidonic acid; Comfort G; COX 2; Inflammation

Indexed keywords

1 (7 TERT BUTYL 2,3 DIHYDRO 3,3 DIMETHYLBENZO[B]FURAN 5 YL) 4 CYCLOPROPYL 1 BUTANONE; ACETYLSALICYLIC ACID; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; ANTIRHEUMATIC AGENT; ARACHIDONATE 5 LIPOXYGENASE; ARACHIDONIC ACID; BAICALIN; CATECHIN; CELECOXIB; CHLOROQUINE; CHRYSIN; COMFORT G; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; ETOFYLLINE; FLAVONOID; FLURBIPROFEN; GREEN TEA EXTRACT; IBUPROFEN; INDOMETACIN; LEVOTHYROXINE SODIUM; LICOFELONE; NEXRUTINE; NITROPELET; NONSTEROID ANTIINFLAMMATORY AGENT; QUERCETIN; ROFECOXIB; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARACHIDONIC ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GAS CHROMATOGRAPHY; GOUT; HUMAN; KNEE ARTHRITIS; MALE; RHEUMATOID ARTHRITIS; SYNOVIAL FLUID; SYNOVITIS;

EID: 77951064728     PISSN: 12107921     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Namgaldaze, D., Bruene, B. Phospholipase A2 - modified LDL activates the phosphatidylinositol3-kinase-akt pathway and increases cell survival in monocyte cells, Arterioscl. Thromb. Vasc. Biol., 2006, 26, 11, p. 2510-2516.
2. Folch, J., Lees, M., Sloane-Stanley, G. H. A simple method for the isolation and purification of total lipids from animal tissues. J. Biol. Chem., 1957, 226, 1, p. 497-509.
3. Vecka, M., Kunešová, M., Staňková, B. et al. Změny složení mastných kyselin v séru a tukové tkáni u obézních žen po velmi přísné nízkoenergetické dietě. Klin. Biochem. Metab. 2001, 12, 33, 3, p. 119-124.
4. Tvrzická, E., Vecka, M., Staňková, B., Žák, A. Analysis of fatty acids in plasma lipoproteins by gas chromatography- -flame ionization detection. Quantitative aspects. Anal. Chim. Acta, 2002, 465, p. 337-350. (Pubitemid 34876430)
5. Xie, W. L., Robertson, D. L., Simmons, D. L. Mitogen-inducible prostaglandin G/H synthase - a new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res.,1992, 25, 4, p. 249-265.
6. Jia, Qi, Nichols, T. C., Rhoden, E. E. et al. Unigen Pharmaceuticals, Inc.: Identification of free-B-ring flavonoides as potent COX-2 inhibitors, U.S. Patent no. 7192611, 2003.
7. Prokeš, L., Karpaš, L., Pernický, A., Pfleger, R., Votruba, M. Analgetický a protizánětlivý účinek flavonoidů (Comfort-G) In Sborník Nejčastější onemocnění ve stáří, strategie v terapii, diagnostice a následné péči. KREPRO : Hradec Králové 2006, s. 67.
8. Hjelte, L. E., Nilsson, A. Arachidonic acid and ischemic heart disease. J. Nutr., 2005, 135, p. 2271-2273. (Pubitemid 41298399)
9. rd edition, U.S.A., Wiley-Liss : New York 1992, p. 188-189, ISBN 0-471-51348-2.
10. Cassidy, A., De Pascual-Teresa, S. Dietary isoflavones and coronary artery disease-proposed molecular mechanisms of action. In Rimbach, G. et al. Nutrigenomics. CRC Press : London 2005, p. 301-326.
11. Thunder, J., Carlstrom, J., Sun, K. et al. Quercetin- -supplemented diets lower blood pressure and attenuate cardiac hypertrophy in rats with aortic constriction. J. Cardiovasc. Pharmacol., 2006, 47, 4, p. 531-541.
12. Calabro, P., Yeh, E. T. H. Inflammatory vascular markers in atherosclerosis. In Geng, Y. J. Current Topics in Atherosclerosis Research. Nova Science Publishers, Inc. : New York, U.S.A. 2005, p. 49-65.
13. Oestvang, J., Johansen, B. Phospholipase A2: A key regulator of inflammatory signalling and a corrector to fibrosis development in atherosclerosis. Biochem. Biophys. Acta, Molec. Cell. Biol. Lipids, 2006, 176, 11, p. 1309-1316.
14. Bochkov, V. N., Philippova, M., Oskolkova, O. et al. Oxidized phospholipids stimulate angiogenesis via autocrine mechanisms, implicating a novel role for lipid oxidation in evolution of atherosclerotic lesions. Circulation Res., 2006, 99, 8, p. 900-908.
15. Upmacis, R. K., Deeb, R. S., Hajjar, D. P. Oxidative alternations of cyclooxygenase during atherogenesis. Prostaglandins Other Lipid Mediat., 2006, 80, 1-2, p. 1-14.
16. Qiu, H., Gabrielsen, A., Agardh, H. E. et al. Expression of 5-lipoxygenase and leukotriene A4 hydrolase in human atherosclerotic lesions correlates with symptoms of plaque instability. Proc. Nat. Acad. Sci. U.S.A., 2006, 103, 21, p. 8161-8166.
17. Navarro, E, Esteve, M., Olivé, A. et al. Abnormal fatty acid pattern in rheumatoid arthritis. A rationale for treatment with marine and botanical lipids. J. Rheumatol., 2000, 27, 2, s. 298-303.
18. Unigen scientists Table of Content Concerning the Scientific Aspects of Information Necessary to Support Applications for the Placing on the Market of Novel Foods and Novel Food Ingredients, confidential paper. U.S.A., 2007.